Track Every Presidential Action. Understand the Impact.
AI-powered summaries of executive orders, proclamations, and memoranda.
Type
Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries
President Donald Trump’s executive order continues the suspension of the duty-free “de minimis” exemption for low-value imports from all countries, including packages sent through the international postal system. It revises an earlier order to require that most of these shipments pay applicable duties, taxes, fees, and charges, and it directs Customs and Border Protection to collect those charges using updated procedures. For postal shipments, the order sets a temporary duty tied to the import surcharge established on February 20, 2026, and requires carriers or other approved parties to collect and send those payments to CBP. The order says it was issued because the administration determined that systems are now in place to collect these duties and that keeping the suspension in place remains necessary to address the national emergencies identified in earlier Trump orders.
Stay up to date on presidential actions
New executive orders and proclamations, straight to your inbox.
Mar 18, 2026
FREnsuring Truthful Advertising of Products Claiming To Be Made in America
Feb 25, 2026
FRContinuing the Suspension of Duty-Free De Minimis Treatment for All Countries
Feb 03, 2026
FRAddressing Threats to the United States by the Government of Cuba
Nov 07, 2025
FRModifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
On November 4, 2025, President Donald Trump issued Executive Order 14357, which modifies duties related to the synthetic opioid supply chain from China. This order reduces the additional tariff on certain Chinese products from 20% to 10%, effective November 10, 2025. The reduction follows commitments from China to take significant measures to curb the flow of fentanyl and related chemicals to the United States. The order directs the Secretary of Homeland Security to monitor China's compliance and adjust actions as necessary. This adjustment aims to address the national emergency previously declared due to the opioid crisis.
Nov 04, 2025
Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China
President Donald Trump issued an order to reduce the additional tariff on certain Chinese goods from 20% to 10%, effective November 10, 2025. This decision follows commitments from China to take significant measures to curb the flow of fentanyl and related chemicals to the United States. The order modifies previous tariffs imposed to address the synthetic opioid crisis, reflecting progress in negotiations between the two countries. The Secretary of Homeland Security, along with other officials, will continue to monitor China's compliance with its commitments and recommend further actions if necessary. This order aims to manage the national emergency related to the opioid supply chain from China.
Sep 17, 2025
FRPresidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2026
President Donald Trump issued a memorandum identifying major drug transit or illicit drug-producing countries for Fiscal Year 2026. The memorandum lists countries such as Afghanistan, Mexico, and Colombia, among others, based on geographic and economic factors that facilitate drug transit or production. It designates Afghanistan, Bolivia, Burma, Colombia, and Venezuela as having failed to meet international counternarcotics obligations. This action underscores the administration's commitment to combating the national emergency caused by drug trafficking and opioid overdoses, which are a leading cause of death in the U.S. The President also highlights efforts to secure borders and enhance cooperation with neighboring countries to address these issues.
Aug 06, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border
On July 31, 2025, President Donald Trump issued Executive Order 14325 to amend duties in response to the flow of illicit drugs across the U.S.-Canada border. This order increases the additional ad valorem duty rate on certain Canadian products from 25% to 35% as part of ongoing efforts to address a national emergency related to drug trafficking, particularly fentanyl. The order also outlines measures to prevent transshipment and mandates the monitoring of Canada's cooperation in combating drug trafficking. The changes are effective for goods entered for consumption on or after August 1, 2025, and aim to pressure Canada to take more substantial action against drug trafficking organizations.
Aug 05, 2025
FRSuspending Duty-Free De Minimis Treatment for All Countries
On July 30, 2025, President Donald Trump issued Executive Order 14324, suspending the duty-free de minimis treatment for imports from all countries. This action means that low-value shipments, which previously entered the U.S. without duties, will now be subject to applicable tariffs, taxes, and fees. The order was issued to address national emergencies related to drug trafficking and trade imbalances, ensuring that tariffs effectively counter these threats. The suspension applies to shipments not covered by specific exemptions, with a focus on enhancing the collection of duties and preventing evasion through deceptive shipping practices. The order directs the Department of Homeland Security to implement necessary measures for its enforcement.
Jul 31, 2025
Amendment to Duties to Address the Flow of Illicit Drugs Across Our Northern Border
President Donald Trump issued an amendment to increase tariffs on certain Canadian goods in response to Canada's insufficient efforts to curb the flow of illicit drugs, such as fentanyl, across the northern border. This action raises the additional tariff rate from 25% to 35% on specific Canadian products, effective August 1, 2025. The amendment also targets transshipped goods from Canada, imposing a 40% tariff on those that do not qualify under the USMCA. The order aims to pressure Canada into taking more robust measures against drug trafficking and to address any retaliatory actions from Canada.
Apr 17, 2025
FRContinuation of the National Emergency and of the Emergency Authority Relating to the Regulation of the Anchorage and Movement of Russian-Affiliated Vessels to United States Ports
On April 15, 2025, President Donald Trump issued a notice to continue the national emergency concerning the regulation of Russian-affiliated vessels entering U.S. ports. Originally declared on April 21, 2022, this emergency allows the Secretary of Homeland Security to control the anchorage and movement of these vessels. The continuation is justified by ongoing disturbances or threats to international relations involving the Russian Federation. This extension will last for one year and has been documented in the Federal Register and communicated to Congress.
Apr 07, 2025
FRFurther Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports
On April 2, 2025, President Donald Trump issued Executive Order 14256, which amends duties on low-value imports from the People's Republic of China (PRC) to combat the synthetic opioid crisis. This order eliminates the duty-free de minimis exemption for certain low-value products from China and Hong Kong, requiring these imports to be subject to duties when they enter the United States after May 2, 2025. The order mandates that U.S. Customs and Border Protection (CBP) collect these duties and allows for either a 30% ad valorem duty or a specific duty of $25 or $50 per item, depending on the date of entry. This action aims to address deceptive shipping practices that facilitate the entry of illicit substances into the U.S. while maintaining the flow of legitimate international mail.
Apr 02, 2025
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports
President Donald Trump issued an order to amend duties on low-value imports from the People's Republic of China (PRC), including Hong Kong, to address the synthetic opioid crisis. The order eliminates the duty-free treatment for certain low-value shipments, which previously benefited from the *de minimis* exemption, effective May 2, 2025. Shipments valued at $800 or less will now be subject to additional duties, with specific rates applied to postal items. This action aims to curb deceptive shipping practices that contribute to the opioid crisis by ensuring that duties are collected on these imports. The Secretary of Homeland Security is tasked with implementing the order, and a report on its impact is expected within 90 days.
Mar 11, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border
President Donald Trump issued Executive Order 14231 on March 6, 2025, to amend tariffs related to the flow of illicit drugs across the northern border. This order adjusts duties initially imposed in a previous executive order, specifically exempting Canadian automotive parts and components from additional tariffs to support the U.S. automotive industry. It also reduces the tariff on potash from 25% to 10% for certain imports. The changes aim to minimize disruption to the automotive sector while addressing drug flow concerns.
Mar 11, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Southern Border
On March 6, 2025, President Donald Trump issued Executive Order 14232 to amend tariffs related to the flow of illicit drugs across the U.S. southern border. This order adjusts the duties imposed on certain goods from Mexico, specifically exempting automotive parts and components from additional tariffs to support the U.S. automotive industry. Additionally, the tariff on potash not covered by these exemptions is reduced from 25% to 10%. These changes aim to minimize disruptions to the automotive sector while addressing border security concerns.
Mar 07, 2025
FRFurther Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
President Donald Trump issued Executive Order 14228 on March 3, 2025, which amends a previous order to address the synthetic opioid supply chain originating from the People's Republic of China. The order increases tariffs from 10 percent to 20 percent on certain Chinese products as a response to China's inadequate efforts to curb the flow of synthetic opioids, such as fentanyl, into the United States. This action is taken under the authority of the International Emergency Economic Powers Act and aims to pressure China into taking more effective measures against the opioid crisis that poses a threat to U.S. national security, foreign policy, and economy.
Mar 06, 2025
Amendment to Duties to Address the Flow of Illicit Drugs Across Our Southern Border
President Donald Trump issued an amendment to adjust tariffs related to the flow of illicit drugs across the U.S.-Mexico border. This action modifies the tariffs imposed by a previous executive order to minimize disruption to the U.S. automotive industry, which heavily relies on cross-border trade of automotive parts. Specifically, goods from Mexico that are duty-free under certain trade agreements will not face additional tariffs, and the tariff on potash will be reduced from 25% to 10%. These changes take effect on March 7, 2025.
Mar 06, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border
On March 2, 2025, President Donald Trump issued Executive Order 14226, amending previous orders to address the flow of illicit drugs across the U.S.-Canada border. This amendment specifically alters the provision of duty-free de minimis treatment for certain goods, which will no longer apply once the Secretary of Commerce confirms that adequate systems are in place to collect tariffs on these goods. The order aims to tighten control over the importation of goods potentially linked to drug trafficking by ensuring proper tariff collection. This action is part of ongoing efforts to enhance border security and combat the illegal drug trade.
Mar 06, 2025
FRAmendment to Duties To Address the Situation at Our Southern Border
President Donald Trump issued Executive Order 14227 to amend previous orders related to duties at the U.S. southern border. This amendment specifically revises the conditions under which certain goods can receive duty-free treatment. The order states that duty-free de minimis treatment will no longer apply once the Secretary of Commerce confirms that systems are in place to efficiently process and collect applicable tariffs. This action aims to ensure proper tariff collection on goods entering the U.S. from the southern border.